HIMSS Awards Cambridge University Hospitals Stage 6 Status of the International Electronic Medical Record Adoption Model

HIMSS UKHealthcare Information and Management Systems Society has awarded Cambridge University Hospitals (CUH) with Stage 6 of the international Electronic Medical Record Adoption Model (EMRAM). The Healthcare Information and Management Systems Society (HIMSS) is an international organisation dedicated to improving healthcare quality, safety, cost-effectiveness and access, through the best use of IT. It developed an Electronic Medical Record Adoption Model (EMRAM) in 2005, which measures progress and the cumulative capabilities of Electronic Medical Record (EMR) systems within hospitals all over the world. Hospitals that reach Stage 6 (Stage 7 being the highest) have established clear goals for improving safety, minimising errors, and recognising the importance of healthcare IT.

This accreditation, which is the only international standard that recognises the effective use of technology in delivering high quality patient care, was validated following an onsite visit by Healthcare Information and Management Systems Society (HIMSS).

HIMSS inspectors visited CUH to assess the use and adoption of its new Epic electronic patient record (EPR) system, which went live on 26 October 2014 across both of its hospitals - Addenbrooke's and the Rosie. As part of the day-long assessment, inspectors spent time with clinical and administrative staff working in paediatrics, pharmacy, radiology, ICU, the emergency department and medical records, observing the delivery of high quality patient care with the use of a fully integrated EPR.

Effective use of the EPR system was showcased including the delivery of closed loop medication to auto identify the nurse, the patient and the medication; increased patient safety and medication error awareness; and many processes now being paperless due to the implementation of the system.

John Rayner, Director of Professional Development at HIMSS Europe, added: "The distance that the Trust has travelled in such a short period of time really stood out during the site visit. To be awarded a Stage 6 validation in less than 12 months of being live with the new system is quite commendable and a real credit to all concerned. We look forward to working with the trust in the future and will observe their progress with considerable interest."

About HIMSS Analytics in Europe
HIMSS Analytics in Europe provides healthcare organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare IT in Europe. HIMSS Analytics' offerings include database and advisory solutions which encompass market research, IT adoption benchmarking, IT Maturity Models for topics like Electronic Medical Records or Continuity of Care. These offerings are designed to support Management and CIOs, IT Executives and Clinicians from across Europe to compare and measure their progress.

Most Popular Now

IBM Watson Health Recognizes Top-Perform…

IBM (NYSE: IBM) Watson Health® announced its 2020 Fortune/IBM Watson Health 100 Top Hospitals list and 15 Top Health Systems award winners, naming the top-performing hospitals and health systems in...

Chatbots can Ease Medical Providers' Bur…

COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers. Research from the Indiana University Kelley School...

Abbott Receives FDA Approval for New Hea…

Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The...

The New Tattoo: Drawing Electronics on S…

One day, people could monitor their own health conditions by simply picking up a pencil and drawing a bioelectronic device on their skin. In a new study, University of Missouri...

Towards an AI Diagnosis Like the Doctor…

Artificial intelligence (AI) is an important innovation in diagnostics, because it can quickly learn to recognize abnormalities that a doctor would also label as a disease. But the way that...

SARS-CoV-2 Antibody Test from Siemens He…

Public Health England, in partnership with the University of Oxford, recently conducted a head-to-head evaluation of four commercial immunoassay tests available in the UK and used for the detection of...

Researchers Develop Software to Find Dru…

Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria. The program could make it easier to identify the deadly antimicrobial resistant bacteria that...

Philips Introduces First-of-a-Kind Mobil…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India. Designed to meet the critical-care requirements...

Proposed Framework for Integrating Chatb…

While the technology for developing artificial intelligence-powered chatbots has existed for some time, a new viewpoint piece in JAMA lays out the clinical, ethical, and legal aspects that must be...

Clinical-Grade Wearables Offer Continuou…

Although it might be tempting to rely on your fitness tracker to catch early signs of COVID-19, Northwestern University researchers caution that consumer wearables are not sophisticated enough to monitor...

World's Smallest Imaging Device has Hear…

A team of researchers led by the University of Adelaide and University of Stuttgart has used 3D micro-printing to develop the world's smallest, flexible scope for looking inside blood vessels...

Optimizing Neural Networks on a Brain-In…

Many computational properties are maximized when the dynamics of a network are at a "critical point", a state where systems can quickly change their overall characteristics in fundamental ways, transitioning...